Dyslipidemia testing: Why, for whom and when

Maturitas

Volumn 81, Issue 4, 2015, Pages 442-445

  Galema Boers, J M H ^a   Van Lennep, J E Roeters ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Dyslipidemia, Familial hypercholesterolemia; Guidelines; Lipid testing, screening

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID;

AGE; ANTIHYPERTENSIVE THERAPY; ATRIAL FIBRILLATION; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DYSLIPIDEMIA; ETHNICITY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; GENDER; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; UNITED KINGDOM; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DYSLIPIDEMIAS;

CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; HUMANS; LIPIDS; PRIMARY PREVENTION; RISK ASSESSMENT;

EID: 84938197116     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2015.05.012     Document Type: Review

References (19)

1. A. Alwan, and World Health Organization Global status report on noncommunicable diseases 2010 2011 World Health Organization Geneva, Switzerland
2. S. Yusuf, S. Hawken, S. Ounpuu, and et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) - case-control study Lancet 364 2004 937 952
3. N.J. Stone, R.I. Levy, D.S. Fredrickson, and J. Verter Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia Circulation 49 1974 476 488
4. M.A. Austin, C.M. Hutter, R.L. Zimmern, and S.E. Humphries Familial hypercholesterolemia and coronary heart disease: a HuGE association review Am J Epidemiol 160 2004 421 429
5. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, and et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
6. J.B.S. Board Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3) Heart 100 Suppl. 2 2014 ii1 ii67
7. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, and et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 2014 S1 S45
8. S. Rabar, M. Harker, N. O'Flynn, A.S. Wierzbicki, and G. Guideline Development Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance BMJ 349 2014 g4356
9. F. Taylor, M.D. Huffman, A.F. Macedo, and et al. Statins for the primary prevention of cardiovascular disease Cochrane Database Syst Rev 1 2013 CD004816
10. A.M. Gotto Jr. Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin Am J Cardiol 96 2005 8F 34F
11. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
12. G. Rose Sick individuals and sick populations Int J Epidemiol 30 2001 427 432 discussion 33-4
13. K.D. Lawson, E.A. Fenwick, A.C. Pell, and J.P. Pell Comparison of mass and targeted screening strategies for cardiovascular risk: simulation of the effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 3921 people Heart 96 2010 208 212
14. National Collaborating Centre for Primary C, Royal College of General P Identification and management of familial hypercholesterolaemia (FH) full guideline 2008 National Collaborating Centre for Primary Care: Royal College of General Practitioners London
15. L. Flink, J.A. Underberg, J.D. Newman, and E. Gianos The recent national lipid association recommendations: how do they compare to other established dyslipidemia guidelines? Curr Atheroscler Rep 17 2015 494
16. W.S. Weintraub, S.R. Daniels, L.E. Burke, and et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association Circulation 124 2011 967 990
17. D.M. Lloyd-Jones, E.P. Leip, M.G. Larson, and et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age Circulation 113 2006 791 798
18. Force USPST, United S, Agency for Healthcare R, Quality The guide to clinical preventive services, 2014: recommendations of the U.S. Preventive Services Task Force 2014
19. N.D. Weinstein, and P.M. Sandman A model of the precaution adoption process: evidence from home radon testing Health Psychol 11 1992 170 180